SIMCERE PHARMACEUTICAL GROUP Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
SIMCERE PHARMACEUTICAL GROUP reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -CNY 14.40 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2013-04-26
CNY
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2012-12-31 | -14.40M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 151.83M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 184.65M CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 28.87M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|
| 2012-12-31 | -$2.31M 20-F · filed 2013-04-26 |